← Leaderboards
Timothy R Rebbeck
Dana-Farber Cancer Inst
$50,819,475
Attributed
$53,593,029
Total exposure
22
Grants
15
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $4M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$65,291,887 · 25
By mechanism
R01$23,079,583 · 7
P50$12,669,395 · 4
U01$9,126,428 · 1
P60$9,090,893 · 4
P20$3,616,644 · 2
P30$3,484,809 · 2
Top collaborators
- Jinbo Chen6 shared
- Mary Beryl Daly5 shared
- John H Holmes2 shared
Most similar at Dana-Farber Cancer Inst
Same institution · by research overlap
- Rani E George$9,003,170
Others in their field
Top investigators on “Cancer Risk”
- Gregory H Reaman · National Childhood Cancer Foundation$242,495,090
- David Heimbrook · Leidos Biomedical Research, Inc.$222,048,828
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,315,120
- Philip J Disaia · University Of California Irvine$144,085,463
- Mitchell D Schnall · University Of Pennsylvania$138,156,012
- Peter C Adamson · National Childhood Cancer Foundation$128,266,602
Research focus
Cancer RiskMalignant NeoplasmsResourcesMalignant Neoplasm Of ProstateAfrican AmericanGenotypeAfricanRisk FactorsGeneticBaseEnsureProgramsClinical ResearchFundingResearch PersonnelCharacteristicsReportingMortalityBiologicalAffectMutationDiagnosisIncidenceGenes
Grant awards (121)
Genomic and Genomic Variation in Prostate Cancer$981,414
R01 · FY2025 · CA · contact PI
BIDIRECTIONAL TRAINING TO ENHANCE CANCER RESEARCH CAPACITY IN AFRICA$269,587
D43 · FY2025 · CA · contact PI
Genomic and Genomic Variation in Prostate Cancer$56,012
R01 · FY2025 · CA · contact PI
Genomic and Genomic Variation in Prostate Cancer$55,368
R01 · FY2025 · CA · contact PI
Genomic and Genomic Variation in Prostate Cancer$53,769
R01 · FY2025 · CA · contact PI
Genomic and Genomic Variation in Prostate Cancer$48,417
R01 · FY2025 · CA · contact PI
Genomic and Genomic Variation in Prostate Cancer$44,377
R01 · FY2025 · CA · contact PI
Genomic and Genomic Variation in Prostate Cancer$39,354
R01 · FY2025 · CA · contact PI
Genomic and Genomic Variation in Prostate Cancer$19,607
R01 · FY2025 · CA · contact PI
Genomic Diversity of Prostate Cancer Across the African Diaspora$1,256,800
R01 · FY2024 · CA · contact PI
BIDIRECTIONAL TRAINING TO ENHANCE CANCER RESEARCH CAPACITY IN AFRICA$269,902
D43 · FY2024 · CA · contact PI
Administrative supplement to expand cancer clinical trial capacity in sub-Saharan Africa$35,600
D43 · FY2024 · CA · contact PI
Community Outreach and Engagement$1,573,652
P30 · FY2023 · CA · contact PI
Genomic Diversity of Prostate Cancer Across the African Diaspora$1,284,929
R01 · FY2023 · CA · contact PI
BIDIRECTIONAL TRAINING TO ENHANCE CANCER RESEARCH CAPACITY IN AFRICA$269,930
D43 · FY2023 · CA · contact PI
Community Outreach and Engagement$1,573,652
P30 · FY2022 · CA · contact PI
Genomic Diversity of Prostate Cancer Across the African Diaspora$1,324,467
R01 · FY2022 · CA · contact PI
BIDIRECTIONAL TRAINING TO ENHANCE CANCER RESEARCH CAPACITY IN AFRICA$270,001
D43 · FY2022 · CA · contact PI
Precision Assessment and Delivery of Cancer Risks in BRCA 1/2 Mutation Cancers$676,046
R01 · FY2021 · CA · contact PI
BIDIRECTIONAL TRAINING TO ENHANCE CANCER RESEARCH CAPACITY IN AFRICA$273,738
D43 · FY2021 · CA · contact PI
Precision Interception of Aggressive Prostate Cancer in African American Men$1,061,028
P20 · FY2020 · CA · contact PI
Precision Assessment and Delivery of Cancer Risks in BRCA 1/2 Mutation Cancers$681,511
R01 · FY2020 · CA · contact PI
Enhancing Global Diversity in Cancer Clinical Genetics$177,651
R01 · FY2020 · CA · contact PI
Precision Interception of Aggressive Prostate Cancer in African American Men$149,101
P20 · FY2020 · CA · contact PI
Genetics of Prostate Cancer in Africa$1,598,130
U01 · FY2019 · CA · contact PI
Precision Interception of Aggressive Prostate Cancer in African American Men$1,040,256
P20 · FY2019 · CA · contact PI
Precision Assessment and Delivery of Cancer Risks in BRCA 1/2 Mutation Cancers$660,980
R01 · FY2019 · CA · contact PI
Precision Interception of Aggressive Prostate Cancer in African American Men$122,954
P20 · FY2019 · CA · contact PI
Genetics of Prostate Cancer in Africa$119,072
U01 · FY2019 · CA · contact PI
Genetics of Prostate Cancer in Africa$2,000,561
U01 · FY2018 · CA · contact PI
Precision Interception of Aggressive Prostate Cancer in African American Men$1,083,300
P20 · FY2018 · CA · contact PI
Precision Assessment and Delivery of Cancer Risks in BRCA 1/2 Mutation Cancers$642,340
R01 · FY2018 · CA · contact PI
Precision Interception of Aggressive Prostate Cancer in African American Men$160,005
P20 · FY2018 · CA · contact PI
Nutritional Assessment of Cancer Risk in African Men$122,756
U01 · FY2018 · CA · contact PI
Genetics of Prostate Cancer in Africa$1,707,746
U01 · FY2017 · CA · contact PI
Precision Assessment and Delivery of Cancer Risks in BRCA 1/2 Mutation Cancers$732,317
R01 · FY2017 · CA · contact PI
Genetics of Prostate Cancer in Africa$1,714,675
U01 · FY2016 · CA · contact PI
Comprhensive Center of Excellence in Health Disparities$1,317,183
P60 · FY2016 · MD
Molecular Epidemiology of Prostate Cancer Outcomes: Genetics, Multilevel Environ$379,764
P60 · FY2016 · MD · contact PI
Administrative Core$175,827
P60 · FY2016 · MD · contact PI
Research Traiing/Education Core$23,951
P60 · FY2016 · MD · contact PI
Genetics of Prostate Cancer in Africa$1,863,488
U01 · FY2015 · CA · contact PI
Comprhensive Center of Excellence in Health Disparities$1,327,473
P60 · FY2015 · MD
Molecular Epidemiology of Prostate Cancer Outcomes: Genetics, Multilevel Environ$406,990
P60 · FY2015 · MD · contact PI
Administrative Core$128,918
P60 · FY2015 · MD · contact PI
Research Traiing/Education Core$20,393
P60 · FY2015 · MD · contact PI
Comprhensive Center of Excellence in Health Disparities$1,333,813
P60 · FY2014 · MD · contact PI
Molecular Epidemiology of Prostate Cancer Outcomes: Genetics, Multilevel Environ$171,493
P60 · FY2014 · MD · contact PI
Administrative Core$171,490
P60 · FY2014 · MD · contact PI
Research Traiing/Education Core$171,488
P60 · FY2014 · MD · contact PI
Comprhensive Center of Excellence in Health Disparities$1,251,750
P60 · FY2013 · MD · contact PI
Improving the Estimation and Communication of Ovarian Cancer Risk Among BRCA1/2 C$415,658
P50 · FY2013 · CA
Molecular Epidemiology of Prostate Cancer Outcomes: Genetics, Multilevel Environ$86,065
P60 · FY2013 · MD · contact PI
Research Traiing/Education Core$86,064
P60 · FY2013 · MD · contact PI
Administrative Core$86,064
P60 · FY2013 · MD · contact PI
Comprhensive Center of Excellence in Health Disparities$1,366,517
P60 · FY2012 · MD · contact PI
Improving the Estimation and Communication of Ovarian Cancer Risk Among BRCA1/2 C$343,633
P50 · FY2012 · CA
Molecular Epidemiology of Prostate Cancer Outcomes: Genetics, Multilevel Environ$195,218
P60 · FY2012 · MD · contact PI
Research Traiing/Education Core$195,216
P60 · FY2012 · MD · contact PI
Administrative Core$195,216
P60 · FY2012 · MD · contact PI
Improving the Estimation and Communication of Ovarian Cancer Risk Among BRCA1/2 C$418,057
P50 · FY2011 · CA
Prophytactic surgery in carriers of BRCA 1/2 mutations$709,500
R01 · FY2010 · CA · contact PI
Improving the Estimation and Communication of Ovarian Cancer Risk Among BRCA1/2 C$441,569
P50 · FY2010 · CA
Ethnic difference in prostate cancer$251,791
R01 · FY2010 · CA · contact PI
Determinants of Disparity in Prostate Cancer Outcomes$1,123,687
P50 · FY2009 · CA · contact PI
Improving the Estimation and Communication of Ovarian Cancer Risk Among BRCA1/2 C$357,347
P50 · FY2009 · CA
Ethnic difference in prostate cancer$332,423
R01 · FY2009 · CA · contact PI
Ethnic difference in prostate cancer$252,110
R01 · FY2009 · CA · contact PI
CORE--Genes and the Environment$98,806
P30 · FY2009 · ES · contact PI
Prophytactic surgery in carriers of BRCA 1/2 mutations$714,168
R01 · FY2008 · CA · contact PI
Modifiers of Cancer Risk in BRCA 1/2 Mutation Carriers$568,408
R01 · FY2008 · CA · contact PI
Gene Discovery in Melanoma Etiology$288,392
P50 · FY2008 · CA · contact PI
Ethnic difference in prostate cancer$252,419
R01 · FY2008 · CA · contact PI
Determinants of Disparity in Prostate Cancer Outcomes$212,000
P50 · FY2008 · CA · contact PI
CORE--Genes and the Environment$94,154
P30 · FY2008 · ES · contact PI
Determinants of Disparity in Prostate Cancer Outcomes$1,556,754
P50 · FY2007 · CA · contact PI
Prophytactic surgery in carriers of BRCA 1/2 mutations$729,407
R01 · FY2007 · CA · contact PI
Modifiers of Cancer Risk in BRCA 1/2 Mutation Carriers$605,381
R01 · FY2007 · CA · contact PI
Gene Discovery in Melanoma Etiology$291,099
P50 · FY2007 · CA · contact PI
Ethnic difference in prostate cancer$254,498
R01 · FY2007 · CA · contact PI
CORE--Genes and the Environment$91,283
P30 · FY2007 · ES · contact PI
Determinants of Disparity in Prostate Cancer Outcomes$1,716,013
P50 · FY2006 · CA · contact PI
Prophytactic surgery in carriers of BRCA 1/2 mutations$753,481
R01 · FY2006 · CA · contact PI
Modifiers of Cancer Risk in BRCA 1/2 Mutation Carriers$610,463
R01 · FY2006 · CA · contact PI
Ethnic difference in prostate cancer$272,309
R01 · FY2006 · CA · contact PI
Gene Discovery in Melanoma Etiology$172,794
P50 · FY2006 · CA · contact PI
CORE--Genes and the Environment$53,262
P30 · FY2006 · ES · contact PI
Determinants of Disparity in Prostate Cancer Outcomes$1,672,857
P50 · FY2005 · CA
Prophytactic surgery in carriers of BRCA 1/2 mutations$776,362
R01 · FY2005 · CA
Modifiers of Cancer Risk in BRCA 1/2 Mutation Carriers$601,094
R01 · FY2005 · CA
Gene Discovery in Melanoma Etiology$167,224
P50 · FY2005 · CA
BIOLOGICAL MARKERS OF BREAST CANCER &TAMOXIFEN RESPONSE$1,917,538
P01 · FY2004 · CA
Segregation and Racial Disparities in Prostate Cancer$1,635,087
P50 · FY2004 · CA
PROPHYLACTIC SURGERY IN CARRIERS OF BRCA1 AND BRCA2$749,815
R01 · FY2004 · CA
Modifiers of Cancer Risk in BRCA 1/2 Mutation Carriers$598,006
R01 · FY2004 · CA
Pharmacogenetic Epidemiology of Birth Defects and Cancer$237,750
R21 · FY2004 · ES
Gene Discovery in Melanoma Etiology$167,224
P50 · FY2004 · CA
Determinants of Disparity in Prostate Cancer Outcomes$1,690,000
P50 · FY2003 · CA
PROPHYLACTIC SURGERY IN CARRIERS OF BRCA1 AND BRCA2$728,597
R01 · FY2003 · CA
Molecular Epidemiology of Melanoma$469,658
R01 · FY2003 · CA
MOLECULAR EPIDEMIOLOGY OF PROSTATE CANCER$260,321
R01 · FY2003 · CA
Pharmacogenetic Epidemiology of Birth Defects and Cancer$237,750
R21 · FY2003 · ES
MOLECULAR EPIDEMIOLOGY OF PROSTATE CANCER$72,910
R01 · FY2003 · CA
PROPHYLACTIC SURGERY IN CARRIERS OF BRCA1 AND BRCA2$707,790
R01 · FY2002 · CA
Molecular Epidemiology of Melanoma$467,302
R01 · FY2002 · CA
MOLECULAR EPIDEMIOLOGY OF PROSTATE CANCER$252,740
R01 · FY2002 · CA
GENOTYPE/HORMONE INTERACTIONS IN BREAST CANCER SUSCEPTIBILITY$135,290
P01 · FY2002 · CA
MOLECULAR EPIDEMIOLOGY OF PROSTATE CANCER$72,910
R01 · FY2002 · CA
CANDIDATE SUSCEPTIBILITY GENES FOR MELANOMA$0
P50 · FY2002 · CA
PROPHYLACTIC SURGERY IN CARRIERS OF BRCA1 AND BRCA2$688,795
R01 · FY2001 · CA
MOLECULAR EPIDEMIOLOGY OF PROSTATE CANCER$243,989
R01 · FY2001 · CA
GENOTYPE/HORMONE INTERACTIONS IN BREAST CANCER SUSCEPTIBILITY$135,290
P01 · FY2001 · CA
MOLECULAR EPIDEMIOLOGY OF PROSTATE CANCER$72,910
R01 · FY2001 · CA
ETIOLOGIC HETEROGENEITY IN LATE ONSET BREAST CANCER$70,655
R01 · FY2001 · CA
CANDIDATE SUSCEPTIBILITY GENES FOR MELANOMA$0
P50 · FY2001 · CA
PROPHYLACTIC SURGERY IN CARRIERS OF BRCA1 AND BRCA2$772,355
R01 · FY2000 · CA
MOLECULAR EPIDEMIOLOGY OF PROSTATE CANCER$248,467
R01 · FY2000 · CA
ETIOLOGIC HETEROGENEITY IN LATE ONSET BREAST CANCER$158,607
R01 · FY2000 · CA
MOLECULAR EPIDEMIOLOGY OF MELANOMA SUSCEPTIBILITY$100,568
P01 · FY2000 · CA
GENOTYPE/HORMONE INTERACTIONS IN BREAST CANCER SUSCEPTIBILITY$71,191
P01 · FY2000 · CA
MOLECULAR EPIDEMIOLOGY OF PROSTATE CANCER$24,583
R01 · FY2000 · CA